Experiences and best practices from EU Member States - a study of the companies, members of the ARPharM
THE QUESTION
Formation of reference prices as a means of control or management of health funds on the cost of drugs has been established practice in many countries. This pricing mechanism comes from Europe, and now introduced or considered as an option beyond her, although it is proved that the mechanism has a negligible effect on total expenditure on medicines. Formation of reference prices may limit access of patients to the full range of available drugs, with appropriate negative effects on patient care.
Reference pricing mechanisms and associated attributes have been introduced by some governments and health funds in the belief that they control the cost of drugs...
Attachments:
